期刊文献+

西尼罗病毒NS1蛋白特异性单克隆抗体的制备与鉴定 被引量:2

Preparation and characterization of monoclonal antibodies against NS1 protein of West Nile virus
下载PDF
导出
摘要 目的:制备针对西尼罗病毒NS1蛋白的特异性单克隆抗体。方法:以原核表达的重组NS1蛋白为免疫原,免疫BALB/c小鼠并通过常规杂交瘤技术将免疫后小鼠脾细胞与SP2/0细胞进行融合。以真核表达的重组NS1蛋白为检测用抗原,建立间接ELISA检测方法筛选分泌NS1蛋白单克隆抗体的杂交瘤细胞。并利用Western blot和IFA试验对所获得的单克隆抗体进行鉴定。结果:共获得了2株稳定分泌NS1蛋白单克隆抗体的杂交瘤细胞株,分别命名为WN-1C10和WN-3D10,其亚类鉴定分别属于IgG2a和IgG1。这2株单克隆抗体均能与西尼罗病毒NS1蛋白和病毒抗原发生特异性反应,而与日本脑炎病毒无交叉反应。结论:本实验成功制备出针对西尼罗病毒NS1蛋白的特异性单克隆抗体,为我国建立西尼罗病毒与日本脑炎病毒的血清学鉴别诊断方法奠定了基础。 Objective:To prepare monoclonal anti/oodles (McAbs) against NS1 protein of West Nile virus (WNV-NS1). Methods: BALB/c mice were immunized intraperitoneally with the puified NS1 protein expressed by prokaryotie expression system. Then the spleen cells of immunized mouse were fused with SP2/0 myeloma cells by the PEG regent. Meanwhile, an indirect ELISA using the purified NSI protein derived from eukaryotic expression system as antigen was developed to screen antiboxty-produeing hybridomas. Western blot and IFA were applied to characterize the McAbs. Results: Two hybridoma cell strains secreting McAbs against WNV-NS1 protein, designated as WN-1CI0 and WN3D10, were obtained. Conclusion:The results of Western blot and IFA indicate that these two McAbs are specific for WNV-NS1 protein, and don't cross-react with Japanese encephalitis virus (JEV), so they are helpful to develop differential diagnosis between WNV and JEV.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第6期529-532,共4页 Chinese Journal of Immunology
基金 国家高技术研究与发展计划(863)项目(No.2007AA02Z406) 兽医生物技术国家重点实验室自主研究课题(SKLVBP201018)的资助
关键词 西尼罗病毒 NS1蛋白 单克隆抗体 West Nile vires NS1 protein Monoelonal antibody
  • 相关文献

参考文献13

  • 1陶三菊.西尼罗病毒病新发传染病的预防与控制[M].北京:中国协和医科大学出版社,2002:414419.
  • 2Murgue B, Zeller H, Deubel V. The ecology and epidemiology of West Nile virus in Africa, Europe and Asia[J]. Curr Top Microbiol Immunol, 2002; 267 : 195-221.
  • 3Dauphin G, Zientara S, Zeller Het al. West Nile:worldwide current situa- tion in animals and humans [ J ]. Comp Immunol Microbiol Infect Dis, 2004;27(5) :343-355.
  • 4Tsai T F, Popovici F, Cemescu C et al. West Nile encephalitis epidemic in soudmastem Rommfia[J]. Lancet, 1998;352(9130):767-771.
  • 5Dauphin G, Zientara S. West Nile virus: recent trends in diagnosis and vaccine development [ J ]. Vaccine, 2007; 25 (30) : 5563-5576.
  • 6Petersen L R, Roehrig J T. West Nile virus: a reemerging global pathogen [J]. Emerg Infect Dis,2001 ;7(4) :611-614.
  • 7Hirota J, Nishi H, Matsuda Het al. Cross-reactivity of Japanese encephali- tis virus-vacclnated horse sera in serediagnosis of West Nile virus[J]. J Vet Med Sci, 2010; 72 (3) : 369-372.
  • 8Shu P Y,Chen L K,Chang S F et al. Antibody to the nonstructural pro- tein NS1 of Japanese encephalitis virus: potential application of mAb- based indirect ELISA to differentiate infection from vaccination [ J ]. Vac- cine, 2001 ; 19(13-14) : 1753-1763.
  • 9Wang B, Hua R H, Tian Z Jet al. Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus [J]. Virus Research, 2009 ; 141 ( 1 ) :90-95.
  • 10Jiang L, Zhou J M, Yin Yet al. Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2[J]. Virus Research, 2010; 150(1-2) :49-55.

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部